 |
JOURNAL TOOLS |
| Publishing options |
| eTOC |
| To subscribe |
| Submit an article |
| Recommend to your librarian |
ARTICLE TOOLS |
| Publication history |
| Reprints |
| Permissions |
| Cite this article as |
| Share |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
CASE REPORT
Gazzetta Medica Italiana Archivio per le Scienze Mediche 2018 November;177(11):667-9
DOI: 10.23736/S0393-3660.17.03639-7
Copyright © 2017 EDIZIONI MINERVA MEDICA
language: English
Tenofovir avoids hepatitis B transmission
Rui GASPAR ✉, Susana LOPES, Guilherme MACEDO
Department of Gastrenterology, São João Hospital Center, Faculty of Medicine, University of Porto, Porto, Portugal
Chronic hepatitis B virus (HBV) infection is a worldwide healthcare problem. Mother-to-child transmission (MTCT) is the main route of transmission. Immunoprophylaxis has been shown to contain the spread of HBV and pregnant women with chronic HBV infection require specialized hepatitis B management. We report a family with history of HBV infection, in which mother to child transmission was prevented on the second generation neonates under the use of tenofovir.
KEY WORDS: Hepatitis B - Infectious disease transmission, vertical - Immunization